Barton Haynes MD
Professor, Medicine, Duke University School of Medicine
Join to View Full Profile
2100 Erwin RdDurham, NC 27705
Phone+1 919-620-4467
Dr. Haynes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalResidency, Internal Medicine, 1973 - 1975
Baylor College of MedicineClass of 1973
Certifications & Licensure
NC State Medical License 1980 - 2025
TX State Medical License 1973 - 2012
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Clinical & Laboratory Immunology
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1997
- Elected Member The American Society for Clinical Investigation, 1983
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- Structural and antigenic characterization of novel and diverse Henipavirus glycoproteins.Aaron J May, Muralikrishna Lella, Jared Lindenberger, Alex Berkman, Ujjwal Kumar
Biorxiv. 2025-04-10 - Safety and implementation of phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns.Avy Violari, Kennedy Otwombe, William Hahn, Shiyu Chen, Deirdre Josipovic
The Journal of Clinical Investigation. 2025-04-03 - Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV Challenge.Dieter Mielke, Marina Tuyishime, Natasha S Kelkar, Yunfei Wang, Robert Parks
Vaccines. 2025-02-24
Press Mentions
How Broadly Neutralizing Antibodies Are Driving Next-Gen VaccinesJanuary 23rd, 2025- Broadly Neutralizing Antibodies: The Key to Next-Generation Vaccine BreakthroughsJanuary 23rd, 2025
- In a 1st, HIV Vaccine Triggers Rare and Elusive Antibodies in Human PatientsMay 21st, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
